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Purpose: Neonates born to mothers with obesity or gestational diabetes mellitus (GDM)
have an increased chance of various metabolic disorders later in life. In India, it is unclear
whether maternal obesity or GDM is related to offspring adiposity. We aimed to understand
the independent effect of maternal obesity and GDM with neonatal adiposity and whether
GDM has a mediating effect between maternal obesity and neonatal adiposity.
Methods: We recruited a cohort of 1120 women (between April 2016 and February 2019)
from the public hospitals in Bangalore, India, who voluntarily agreed to participate and
provided written informed consent. The primary outcome was neonatal adiposity, deﬁned as
the sum of skinfold thickness >85th percentile. Exposure included maternal obesity, deﬁned
as >90th percentile of skinfold thickness. GDM, the potential mediator, was classiﬁed using
the World Health Organization criteria by oral glucose tolerance test. Binary logistic regres-
sion was applied to test the effect of maternal obesity and GDM on neonatal adiposity,
adjusting for potential confounders. We used Paramed command in STATA version 14 for
analyzing mediating effects.
Results: We found that maternal obesity (odds ratio (OR)=2.16, 95% CI 1.46, 3.18) and
GDM (OR=2.21, 95% CI1.38, 3.52) have an independent effect on neonatal adiposity. GDM
signiﬁcantly mediates 25.2% of the total effect between maternal obesity and neonatal
adiposity, (natural direct effect OR = 1.16 95% CI 1.04, 1.30) with signiﬁcant direct effect
of maternal obesity (natural direct effect OR = 1.90 95% CI 1.16, 3.10) and signiﬁcant total
effect (OR=2.20 95% CI 1.35, 3.58).
Conclusion: We showed that maternal obesity and GDM are independently associated with
offspring adiposity. Also, GDM mediates the association of maternal obesity on adiposity in
children. Interventions focused on obesity prevention in women, and effective screening and
management of GDM may contribute to reducing childhood obesity in India.
Keywords: mediation effects, skinfold thickness, GDM, obesity in pregnancy, childhood
obesity
Introduction
Obesity in pregnancy is a signiﬁcant public health concern as it increases the risk
of several complications during pregnancy and the perinatal period.1,2 Nearly
4.3 million pregnant women are overweight or obese in India, reﬂecting the high
prevalence of overweight and obesity in low-middle income countries
(LMICs).3,4 Also, it is known that children are twice as likely to have obesity
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if their mothers were obese during the ﬁrst trimester of
pregnancy.5 Maternal obesity results in fetal
macrosomia.6–10 Also, obesity during pregnancy signiﬁ-
cantly predisposes pregnant women to develop
Gestational diabetes mellitus (GDM), deﬁned as hyper-
glycaemia that ﬁrst develops during pregnancy or ﬁrst
diagnosed during pregnancy. Several mechanisms sug-
gest higher risk of developing GDM in obese women.
These include higher insulin resistance in obese women
compared to women of healthy weight, leading to the
increased availability of lipids for fetal growth and
development.11,12 GDM affects more than 17.8 million
women worldwide, among whom 28% are in India.13
Maternal obesity and Gestational diabetes mellitus
(GDM) are associated with several adverse effects in
mothers as well as children during pregnancy and
beyond. These include higher cesarean section rate, pre-
term delivery, fetal macrosomia, and fetal death.6,14–20
A recent meta-analysis found that obesity during preg-
nancy increases the risk of fetal adiposity, with risk
rising across the overweight and obese categories
proportionately.21 Moreover, GDM results in several
adverse fetal implications. Babies of women with GDM
are prone to develop adiposity, characterized by substan-
tial fat deposition in most skin folds in all areas of the
body.22 Adult-onset obesity and related complications
such as hypertension, Type 2 diabetes mellitus,
Cardiovascular Diseases (CVDs) more likely affect chil-
dren with adiposity.23 Several factors, including maternal
obesity and GDM, are linked to the increasing burden of
fetal adiposity.6,24,25 Evidence suggests that obesity dur-
ing pregnancy is a stronger determinant of fetal adiposity
compared to pre-pregnancy BMI.11
Hitherto, the role of maternal obesity and GDM in
resulting fetal adiposity is mostly studied in high-income
countries.26,27 Understanding the putative causal path of
maternal obesity and fetal adiposity, including the media-
tion role of GDM is essential to prioritize policy planning
and implementation for limiting the adverse effects of
these conditions.28 In the Indian context, it is unclear as
to what degree of maternal obesity and GDM contribute,
and whether they are related to each other in resulting
adiposity in children. Since two-thirds of pregnant
women in India use the public hospitals for the antenatal
care services,29 we aimed to understand the extent of
association of maternal obesity with adiposity in neonates,
and the mediating role of this association by GDM using
a cohort study of women of public hospitals in India.
Materials and Methods
Study Sample, Data Collection, and Ethics
Consideration
We established a pregnancy cohort in April 2016, titled as
the “Maternal Antecedents of Adiposity Studying the
Transgenerational role of Hyperglycemia and Insulin”
(MAASTHI). We have published a detailed protocol
earlier.30 In brief, we approached women in the waiting
area of public hospitals and explained the study in detail
and included them if they voluntarily agreed to participate
and provided written informed consent. We included preg-
nant women aged above 18 years, in their second trimester
(within 36 gestational weeks) visiting and planning to deliver
in three public hospitals with their residence in the nearby
study area. We excluded participants with severe, past, or
current illness or their inability to complete the oral glucose
tolerance test (OGTT) before 36 weeks of gestation.
After obtaining written informed consent, our trained
research staff recruited eligible pregnant women and con-
ducted face-to-face interviews by ensuring privacy and
conﬁdentiality. Interview details included socio-
demographic information, use of tobacco and alcohol,
family history of diabetes and cardiovascular diseases
(CVD), obstetric history, and assessment of psychosocial
environment using a validated version of the Edinburgh
Postnatal Depression Scale (EPDS), and social support
scale. We measured the physical activity of pregnant
mothers using a validated Physical Activity Level (PAL)
questionnaire.31 The questionnaire had ﬁve domains:
exercise, hobbies, household chores, sedentary activities,
and other common daily activities. These domains
include all the activities performed by women in an
urban setting. Metabolic Equivalent (MET) values of
each activity were then calculated by multiplying three
components, namely MET allotted value, duration of
activity done, and frequency done in a week. The com-
bined MET value was calculated by adding MET values
of individual physical activity. Categorization of the com-
bined score was done, and the level of physical activity
was deﬁned as “low” if it was <600 METs, “moderate”
when 600–2999 METs, and as “high” when it is ≥3000
METs.
For the current analyses, we used data from April 2016
to February 2019. Research assistants entered all data in
a validated application on an Android device.
The study protocol was reviewed and approved by the
Institutional Ethics Committee of the Indian Institute of
Babu et al Dovepress
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Public Health, Bangalore campus (IEC no: IIPHHB/
TRCIEC/091/2015; dated 13/11/2015). The study was
conducted in accordance with the Declaration of Helsinki.
Exposure Assessment – Maternal Obesity
Maternal height, weight, and the sum of skinfold thickness
(SFT) measurement at three sites (biceps, triceps, and
subscapular) was measured during the hospital visit of
the participant using a calibrated portable stadiometer
(SECA 213), digital weighing scale (Tanita), and Holtain
Calipers (Holtain, UK) respectively. Two readings for
weight and height and three readings for skinfold thickness
measurements were taken. Women were considered obese
- if the sum of skinfold thickness was higher than the 90th
percentile of the distribution of the sum of skinfold thick-
ness in the study sample. Research assistants were trained
and certiﬁed in anthropometry at the beginning of the
study and then annually to obtain accurate measurements
and to avoid inter- and intra-observer variation. All anthro-
pometric equipment were calibrated and validated every
month using standardized weights and scales.
GDM Diagnosis
Between 24 to 36 weeks of gestation, we invited the parti-
cipants to undergo a 2 hr 75 grams oral glucose tolerance test
(OGTT) after overnight fasting for at least eight hours.32 We
collected 2mL blood in fasting and 2 hr postprandial for
glucose analysis. We followed the WHO diagnostic criteria
developed by the International Association of Diabetes and
Pregnancy Study Group (IADPSG) for the classiﬁcation of
gestational diabetes mellitus (GDM). Accordingly, GDM
was diagnosed if the fasting blood sugar (FBS) was equal
to or more than 92 mg/dL, and 2 hr postprandial blood sugar
(PPBS) equal to or more than 153 mg/dL.33
Neonatal Adiposity
We collected details at birth through structured inter-
views and anthropometric measurements within seven
days of the birth of the child. Anthropometric measure-
ments included weight, length, crown-rump length
(CRL), circumferences – head, chest, waist, hip, middle-
upper arm (MUAC), and skinfold thickness. We weighed
the neonates on the calibrated digital weighing scale
(SECA 354), with two readings taken to the nearest
0.5g. We measured crown-heel and crown-rump length
using SECA 417 infantometer to the nearest 0.1 cm.
We used the Chasmors body circumference tape to mea-
sure circumferences, with two readings taken to the
nearest 0.1 cm. We measured the skinfold thickness in
neonates using Holtain Calipers (Holtain, UK) at three
sites, namely biceps, triceps, and subscapular areas. The
sum of skinfold thickness was calculated (SFT), and
centile charts for the sum were determined. A neonate
was classiﬁed as having excessive fat deposition (adip-
osity) if SFT was above the 85th percentile for the neo-
nate’s gestational age. Indian standard for classiﬁcation
of neonates based on the sex and order of the birth was
used for the weight for gestational age.34 The primary
information regarding gestational age, parity, and sex
from the cohort were used to derive the variable, weight
for gestational age. Hence a neonate weighing less than
the 10th percentile was classiﬁed as small for gestational
age (SGA), between 10 to 90th percentile was appropri-
ate for gestational age (AGA) or healthy, and higher than
90th percentile was large for gestational age (LGA).34
Confounders
Confounders were selected based on literature review and
included a priori in the analyses. Studies have shown that
GDM signiﬁcantly and progressively increases due to
increased age; the other confounders include parity and
family history of diabetes.35 We also adjusted for maternal
obesity as measured through the sum of skinfold thickness
measured during pregnancy, as they are closely
correlated.36,37 Maternal height is an independent risk
factor for GDM.37,38 The religion of the respondent, hus-
band’s income, and alcohol intake were also adjusted.39
We also adjusted for physical activity (MET values), as
increased physical activity is associated with decreased
neonatal adiposity,40 and reduced rates of GDM.41
Statistical Analysis
Power analysis was performed for testing mediation effect
in multiple logistic regression by a method proposed by
Vittinghoff, Sen, and McCulloch’s using the “R”
package.42 The power of the study was 99% considering
n=1120, the regression coefﬁcient of GDM (after adjusting
for confounders) =1.99, the standard deviation of GDM =
0.370, the prevalence of neonatal obesity =0.146, multiple
correlations of GDM with the confounders and neonatal
obesity =0.048 and level of signiﬁcance = 0.05.
We cleaned and organized the data ahead of performing
analysis using STATA version 14. A total of 1120 observa-
tions were considered for the analysis, of which 1091 were
included for SFT analysis. Missing data were analyzed using
available case analysis. Categorical variables were expressed
Dovepress Babu et al
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as frequency (f) and percentages (%) and normally distrib-
uted as mean and standard deviation. Association between
various socio-demographic factors to GDM, Obesity, SFT,
and weight for gestational age were assessed using the Chi-
square test and Fisher’s exact test when appropriate.
We used univariate logistic regression to test the inde-
pendent effect of maternal obesity and GDM on neonatal
adiposity. Homogeneity of odds ratio (Breslow-Day test)
across the levels of GDM and test of conditional indepen-
dence was assessed using the Mantel Haenszel test.
Multiple logistic regression was adopted to adjust for
potential confounders. We evaluated multicollinearity
among the confounders using a correlation matrix; no
multicollinearity if the correlation was less than 0.90.
Multicollinearity between exposure and mediator was
assessed using the variance inﬂation factor (VIF) using
linear regression, as suggested by Midi H for logistic
regression models.43
Four separate models were performed and compared
using different model diagnostics (Likelihood value,
Hosmer & Lemeshow test of the goodness of ﬁt,
Nagelkerke R Square, and classiﬁcation accuracy).
Model 1 shows the association of maternal obesity on
neonatal adiposity adjusting for confounders. Model 2
shows the association of GDM on neonatal adiposity
adjusting for confounders. Model 3 shows the association
of maternal obesity, GDM on neonatal adiposity adjusting
for confounders (with interaction). Model 4 shows the
association of maternal obesity, GDM on neonatal adipos-
ity adjusting for confounders (without interaction). We
report the odds ratio (OR) with 95% conﬁdence interval
(CI) and p values.
The natural direct, natural indirect (mediated by
GDM), and the marginal total effects were estimated
using mediation analysis using the Logit model. We per-
formed a bootstrapping analysis with 1000 replications.
The direct effect= the effect of GDM on the neonatal
adiposity without the effect of GDM, and indirect effect=
the effect of GDM on the neonatal adiposity mediated via
GDM. The product of direct and indirect effects are
expressed as the total effect. We estimated the proportion
mediated,44 using Paramed command,45 as per the
approach suggested by Baron and Kenny.46
Logit {P(neonatal adiposity = 1| maternal obesity, neonatal
adiposity, confounders)} = (β0+β1 maternal obesity
+ β2 GDM) + β3 confounders} —— (a)
Logit {P(GDM = 1| maternal obesity, confounders)} = λ
+ λ1 maternal obesity+λ3 confounders} —— (b)
Results
The characteristics of women (N=1020) and neonates
enrolled in the MAASTHI cohort from 2016 to 2019
based on neonatal adiposity and large for gestational age
(LGA) are presented in Table 1. Among the neonates born
during the cohort, 14.6% had SFT >85th percentile and
were large for gestational age (n=163/1120). Almost all
children born in the group were reportedly healthy during
assessment after birth. We found that less than 3.6%
reported aspiration of babies while resuscitation was
reported in 42% obese babies and 23.6% of babies with
LGA. Additionally, 4.3% of neonates with adiposity did
not cry soon after delivery compared to less than 2% LGA
neonates (Table 1).
The characteristics of pregnant women and neonates
based on maternal GDM and obesity status are provided in
Table 2. Out of the total participants, 9.7% of the mothers
were obese, and 16.4% were diagnosed with GDM. We
found that 62.4% (n=109) obese and 52.2% (n=184) with
GDM were Muslims. In our study sample, approximately
seven out of 10 women with obesity (70.7%) and nearly
two-thirds of women with GDM (63.5%) were multipar-
ous. Infertility was reported in women with GDM as well
as among women with obesity. Some form of resuscitation
was reported in 34.9% of babies born to women with
obesity, and 36% of babies born to GDM mothers
(Table 2).
As seen in Table 3, women with obesity delivered
a higher proportion of babies with large birth weight
than mothers without obesity (18.3% vs 9.1%).
Similarly, women with GDM also delivered a higher
proportion of babies with large birth weight compared
to non-GDM women (18.5% vs 8.3%). Further, com-
pared to women without obesity, babies born to women
with obesity had higher head (8.9% vs 12.8%), chest
(8.3% vs 12.8%), and middle-upper arm circumference
(9.0% vs 18.3%); similarly women with GDM delivered
higher proportion of babies with larger MUAC than
non-GDM mothers (16.8% vs 8.3%). The percentage
of babies with adiposity (>85th percentile of the sum
of skinfold thickness) was higher among women with
obesity (25.7% vs 13.5%) and women with GDM
(23.9% vs 12.7%) when compared to their respective
control groups. (Table 3)
Babu et al Dovepress
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Table 1 Descriptive Statistics of Maternal and Neonatal Characteristics in Relation to Neonatal Adiposity and Large for Gestational
Age (LGA) in MAASTHI Cohort 2016–19, India
Characteristics Categories Sum of Skinfold Thickness Weight for Gestational Age
≤85th
Percentile
(n=957)
>85th
Percentile
(n=163)
p value ≤90th
Percentile
(n=957)
>90th
Percentile
(n=163)
p value
f (%) f (%) f (%) f (%)
Maternal Agea 24.24±4.03 24.25±4.03 0.96 24.12±3.99 25.94±4.22 0.02
Religion Hinduism 458(48%) 78(47.9%) 0.79 427(46.4%) 24(43.6%) 0.08
Christianity 31(3.2%) 7(4.3%) 30(3.3%) 5(9.1%)
Islam 466(48.8%) 78(47.9%) 463(50.3%) 26(47.3%)
Participant’s Education Primary school
and below
68(7.1%) 11(6.7%) 0.86 68(7.4%) 3(5.5%) 0.59
Middle school
and above
887(92.9%) 152(93.3%) 852(92.6%) 52(94.5%)
Husband’s Education Primary school
and below
182(19.1%) 37(22.7%) 0.28 184(20%) 11(20.0%) 1.000
Middle school
and above
773(80.9%) 126(77.3%) 736(80.0%) 44(80.0%)
Participant’s current
occupation
Unemployed 894(93.4%) 147(90.2%) 0.17 862(93.7%) 51(92.7%) 0.81#
Unskilled
worker
44(4.6%) 9(5.5%) 39(4.2%) 3(5.5%)
Skilled workers 19(2.0%) 7(4.3%) 19(2.1%) 1(1.8%)
Parity Nulliparous 417(43.6%) 65(39.9%) 0.37 414(45.0%) 24(43.6%) 0.84
Multiparous 539(56.4%) 98(60.1%) 506 (55.0%) 31(56.4%)
Family history of diabetes None 748(78.4%) 123(75.5%) 0.38 718(78.3%) 41(74.5%) 0.78
One parent 182(19.1%) 33(20.2%) 175(19.1%) 12(21.8%)
Both parent 24(2.5%) 7(4.3%) 24(2.6%) 2(3.6%)
Participant’s history of GDM Yes 10(1.0%) 3(1.8%) 0.42# 10(1.1%) 1(1.8%) 0.47#
Participant’s history of
Hypertension
Yes 13(1.4%) 2(1.2%) 1.000# 14(1.5%) 0 1.000#
Participant’s history of
Anaemia
Yes 418(43.8%) 67(41.1%) 0.53 394(42.9%) 25(45.5%) 0.71
Current GDM status during
assessment
Yes 140(14.6%) 44(27.0%) <0.001 148(16.1%) 20(36.4%) <0.001
Current Hypertension status
during the assessment
Yes 41(4.4%) 14(9.2%) 0.01 47(5.3%) 4(7.4%) 0.53#
Participant’s obesity status Yes 81(8.7%) 28(17.4%) 0.001 91(10.1%) 10(18.9%) 0.05
Husband’s alcohol
consumption
Yes 130(13.8%) 28(17.5%) 0.208 119(13.1%) 9 (16.4%) 0.5
(Continued)
Dovepress Babu et al
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Independent Effect
Univariate logistic regression was performed to determine
the independent effects of GDM and maternal obesity with
neonatal adiposity. We found that both GDM and maternal
obesity have an independent impact on neonatal adiposity,
maternal obesity OR=2.16 (95% CI 1.46, 3.18), and GDM
OR=2.21(95% CI1.38, 3.52) respectively (Table 4). The
homogeneity of odds ratio across the levels of GDM using
the Breslow-Day test was insigniﬁcant (χ2=0.14, p-value
=0.71), indicating that the association between GDM and
neonatal adiposity did not differ signiﬁcantly between
women with and without GDM. The test of conditional
independence using Mantel Haenszel indicated that maternal
obesity and neonatal adiposity are conditionally independent,
given the status of maternal obesity (p-value =0.008) and also
vice versa (p-value =0.002) (data not present in the table).
Adjusted Effect
The results of the multiple Binary logistic regressions for
four models are also shown in Table 4. Due to multi-
collinearity among gravida and parity, we performed sepa-
rate multiple regression models to choose the best model.
Based on the Likelihood ratio test, parity was better than
gravida in model ﬁtting. The ﬁnal model included GDM,
maternal obesity, religion, MET values, participant’s his-
tory of diabetes, parity, family history of diabetes, hus-
band’s alcohol consumption status, maternal age,
husband’s income, and participant’s height. Four separate
models were performed and compared using different
model diagnostics. We observed no signiﬁcant multiplica-
tive interaction between maternal obesity and GDM (p
value=0.78). The likelihood value, Hosmer & Lemeshow
test of the goodness of ﬁt, Nagelkerke R Square, and
Table 1 (Continued).
Characteristics Categories Sum of Skinfold Thickness Weight for Gestational Age
≤85th
Percentile
(n=957)
>85th
Percentile
(n=163)
p value ≤90th
Percentile
(n=957)
>90th
Percentile
(n=163)
p value
f (%) f (%) f (%) f (%)
Delivery type Spontaneous
vaginal delivery
506(52.9%) 79(48.5%) 0.54# 484(52.6%) 23(41.8%) 0.34#
Emergency
caesarean
270(28.2%) 55(33.7%) 270(29.3%) 21(38.2%)
Elective
caesarean
179(18.7%) 29(17.8%) 164(17.8%) 11(2%)
Outlet forceps
delivery
2(0.2%) 0 2(0.2%) 0
Health status of the mother Healthy 818(85.5%) 136(83.4%) 0.5 784(85.2%) 46(83.6%) 0.75
Illness present 139(14.5%) 27(16.6%) 136(14.8%) 9(16.4%)
Health status of the baby Healthy 950(99.3%) 161(98.8%) 0.63# 914(99.3%) 55(100%) 1.000#
Diseased 7(0.7%) 2(1.2%) 6(0.7%) 0
Sex Male 480(50.2%) 87(53.4%) 0.45 455(49.5%) 31(56.4%) 0.32
Female 477(49.8%) 76(46.6%) 465(50.5%) 24(43.6%)
Baby cried soon after
delivery
Yes 938(98.0%) 156(95.7%) 0.09# 900(97.8%) 54(98.2%) 1.000#
Aspiration Yes 23(2.4%) 3(1.8%) 1.000# 19(2.1%) 2(3.6%) 0.33#
Resuscitation Yes 321(34.2%) 47(42.0%) 0.013 309(33.6%) 13(23.6%) 0.13
Notes: aMean±standard deviation is mentioned instead of frequency and percentage with an independent sample t-test, p-value. #Fishers exact test p-value. Bold indicates
statistical signiﬁcance at 5%.
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Table 2 Descriptive Statistics of Maternal and Neonatal Characteristics in Relation to Maternal Obesity and Gestational Diabetes
Mellitus (GDM) in MAASTHI Cohort 2016–19, India
Characteristics Maternal Obesity Statusb GDM Statusc
Yes
(n=109)
No
(n=982)
p value Yes
(n=184)
No
(n=936)
p value
f (%) f (%) f (%) f (%)
Maternal Agea 25.14±4.23 24.16±4.0 0.02 25.37±4.25 24.01±3.95 <0.001
Religion Hinduism 37(33.9%) 482(49.1%) 0.01 83(45.1%) 453(48.5%) 0.54
Christianity 4(3.7%) 34(3.5%) 5(2.7%) 33(3.5%)
Islam 68(62.4%) 466(47.5%) 96(52.2%) 448(48.0%)
Participant’s Education Primary school and
below
4(3.7%) 73(7.4%) 0.15 14(7.6%) 65(7.0%) 0.75
Middle school and above 105(96.3%) 909(92.6%) 170(92.4%) 869(93.0%)
Parity Nulliparous 32(29.4%) 436(44.4%) 0.003 67(36.4%) 415(44.4%) 0.05
Multiparous 77(70.7%) 546(55.6%) 117(63.5%) 520
(55.7%)
Family history of diabetes None 74(67.9%) 771(78.8%) 0.03 749(80.3%) 122(66.3%) <0.001
One parent 30(27.5%) 182(18.6%) 162(17.4%) 53(28.8%)
Both parent 5(4.6%) 26(2.7%) 22(2.4%) 9(4.9%)
Participant’s history of Infertility
treatment
Yes 4(3.7%) 9(0.9%) 0.03# 6(3.3%) 7(0.8%) 0.004
Participant’s history of GDM Yes 3(2.8%) 9(0.9%) 0.11# 1(0.5%) 12(1.3%) 0.71#
Participant’s history of Hypertension Yes 3(2.8%) 12(1.2%) 0.19# 14(1.5%) 1(1.0%) 0.49#
Metabolic Equivalents (MET) value Low 1(0.9%) 21(2.2%) 0.72# 3(1.7%) 19(2.1%) 1.000#
Moderate 107(99.1%) 950(97.8%) 177(98.3%) 904(97.9%)
EPDS score** ≤13 101(92.7%) 897(91.3%) 0.64 856(91.6%) 168(91.3%) 0.91
> 13 8(7.3%) 85(8.7%) 79(8.4%) 16(8.7%)
Husband’s tobacco use Yes 51(46.8%) 397(41.0%) 0.25 83(45.4%) 378(41%) 0.28
Delivery type Spontaneous vaginal
delivery
52(47.7%) 516(52.5%) 0.45# 78(42%) 507(54.2%) 0.024#
Emergency caesarean
section
31(28.4%) 288(29.3%) 66(36%) 259(27.7%)
Elective caesarean
section
26(23.9%) 176(17.9%) 40(22%) 168(17.9%)
Vacuum extraction 0 2(0.2%) 0 2(0.2%)
Health status of the baby Healthy 108(99.1%) 974(99.2%) 1.000# 183(100%) 928(99.1%) 1.000#
Diseased 1(0.9%) 8(0.8%) 1(1.0%) 8(0.8%)
(Continued)
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classiﬁcation accuracy suggested that model 4 is a better
ﬁt to the data than models 1, 2, and 3. Our results indicated
that the odds of having adiposity in babies were 1.90 times
higher for women with obesity (95% CI: 1.16, 3.12) and
1.99 times higher for women with GDM (95% CI: 1.31,
3.02) adjusting for other confounders.
Mediation Analysis (Table 5)
Model (a) and (b) from the equations were ﬁtted for
mediation analysis. These models were ﬁtted with no
interaction and no multicollinearity (VIF=1.03) between
exposure and mediator but adjusted for potential confoun-
ders. GDM signiﬁcantly mediates the relationship between
maternal obesity and neonatal adiposity, (natural direct
effect OR = 1.16 95% CI 1.04, 1.30) with signiﬁcant direct
effect of maternal obesity (natural direct effect OR = 1.90
95% CI 1.16, 3.10) and signiﬁcant total effect (OR=2.20
95% CI 1.35, 3.58). The results indicate that GDM med-
iates 25.2% of the total effect of maternal obesity and
neonatal adiposity. With 1000 replications, there were no
signiﬁcant differences in the conﬁdence intervals
(Table 5).
Discussion
We aimed to understand how maternal obesity and GDM
during pregnancy are associated with adiposity in the off-
spring. Our results suggest that both maternal obesity and
GDM are independently associated with adiposity in neo-
nates. While neonates born to women with GDM show
association with most of the anthropometric markers of
adiposity, such association was seen only for birth weight
and middle-upper arm circumference in neonates borne to
with women with obesity. This ﬁnding is corroborated by
other studies demonstrating that obesity in offspring is
associated with maternal GDM and obesity.47–52 Further,
results from the regression models showed that GDM is
a stronger determinant of adiposity in neonates and med-
iates the effect of maternal obesity on neonatal adiposity.
These results suggest that the risk factors for adiposity in
neonates are to be addressed by using a life course
perspective.
India is undergoing a rapid epidemiological and demo-
graphical transition.53 Since GDM affects nearly one in
ﬁve Indian pregnant women, our current study suggests
that it is essential to prioritize GDM screening and man-
agement by the policymakers. The Indian national guide-
lines (2014) recommend GDM screening for all pregnant
women during pregnancy.54 However, only 44% of preg-
nant mothers in public health facilities underwent OGTT
as a screening test for GDM.55 Besides, the proportion of
women who complete the test is also low. The results from
public hospitals suggest that women from lower socio-
economic status are equally affected. Therefore, universal
screening might be useful in the timely management of
GDM and in preventing adverse consequences.56,57
Additionally, we also reported that obesity in women is
associated with adiposity in neonates. This suggests that
early intervention preventing or controlling obesity in
young women can end the vicious cycle of obesity across
generations.58 Interventions aimed at addressing nutri-
tional intake, healthy weight, and physical activity directed
at parents can reduce obesity-related health consequences.
Table 2 (Continued).
Characteristics Maternal Obesity Statusb GDM Statusc
Yes
(n=109)
No
(n=982)
p value Yes
(n=184)
No
(n=936)
p value
f (%) f (%) f (%) f (%)
Sex Male 69(63.3%) 486(49.5%) 0.006 106(58%) 461(49.3%) 0.04
Female 40(36.7%) 496(50.5%) 78(42%) 475(50.7%)
Baby cried soon after delivery Yes 106(97.2%) 960(97.8%) 0.73# 180(98%) 914(97.6%) 1.00#
Aspiration Yes 2(1.8%) 22(2.2%) 0.60# 2(1.1%) 24(2.6%) 0.29#
Resuscitation Yes 38(34.9%) 354(36.0%) 0.81 67(36%) 325(34.7%) 0.66
Notes: aMean±standard deviation is mentioned instead of frequency and percentage with an independent sample t-test, p value. bMore than 90th percentile of sum of
skinfold thickness as the obese category. cFasting blood sugar (FBS) equal to or more than 92 mg/dL or 2 hr postprandial blood sugar (PPBS) equal to or more than 152 mg/
dL(32) as GDM. Bold indicates statistical signiﬁcance at 5%. #Fishers exact test p value. **Scores range from 0 to 30.
Abbreviation: EPDS, Edinburgh Postnatal Depression Scale to screen for depression.
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We also reported that instead of birth weight, the skin-
fold thickness of neonates is a reliable marker of adiposity
in identifying adverse consequences in the offspring of
women with obesity and GDM. The relatively high cost
of the calipers and the need for rigorous training and vali-
dation of the measurements by research staff makes it tough
for scaling up in public hospitals. Our results indicate that
a similar positive association is seen with the middle-upper
arm circumference for adiposity in neonates. These indirect
methods of measurements can be used for identifying and
tracking adiposity in neonates, especially in resource-scarce
settings, thus ideal for public hospitals. Previous studies
have shown the measurements of MUAC, and CC as mea-
sures of adiposity are not only comparable to dual-energy
X-ray (DXA) or underwater weighing but also cost-
effective and applicable for larger populations.59–66
Further, we found that GDM mediates 25.2% of the
association between obesity in women with neonatal adip-
osity. Future studies can inform regarding the exact biolo-
gical nature of this mediation mechanism to uncover the
causal path between obesity in mother and neonatal adip-
osity. Maternal obesity has both a direct and indirect effect
on infant adiposity. We show that the clustering of risk
factors of obesity and GDM predisposes infants to NCDs
Table 3 Distribution of Neonatal Anthropometric Characteristics Over Obese and GDM Categories
Neonatal Anthropometric
Characteristics
Categories Maternal Obesity
Status
p value GDM Status p value
Yes
(n=109)
No
(n=982)
Yes
(n=184)
No
(n=936)
f (%) f (%) f (%) f(%)
Birth weight (kg) <10th 10(9.2%) 96(9.8%) 0.0001 11(6.0%) 97(10.4%) 0.01
10th - 90th 79(72.5%) 797(81.2%) 139(75.5%) 761(81.3%)
>90th 20(18.3%) 89(9.1%) 34(18.5%) 78(8.3%)
Crown rump length (cm) <10th 10(9.2%) 99(10.2%) 0.17 14(7.7%) 97(10.4%) 0.14
10th - 90th 88(80.7%) 779(80.1%) 139(76.8%) 751(80.8%)
>90th 11(10.1%) 95(9.8%) 28(15.5%) 82(8.8%)
Length (cm) <10th 12(11.0%) 88(9.0%) 0.33 13(7.1%) 91(9.7%) 0.25
10th - 90th 81(74.3%) 801(81.7%) 149(81.0%) 756(80.9%)
>90th 16(14.7%) 92(9.4%) 22(12.0%) 88(9.4%)
Head Circumference (cm) <10th 9(8.3%) 101(10.3%) 0.01 14(7.6%) 98(10.5%) 0.34
10th - 90th 86(78.0%9) 794(80.9%) 142(77.2%) 762(81.4%)
>90th 14(12.8%) 87(8.9%) 28(15.2%) 76(8.1%)
Chest circumference (cm) <10th 11(10.1%) 93(9.5%) 0.0001 12(6.5%) 99(10.6%) 0.25
10th - 90th 84(77.1%) 807(82.3%) 141(76.6%) 768(82.1%)
>90th 14(12.8%) 81(8.3%) 31(16.8%) 68(7.3%)
Waist circumference (cm) <10th 11(10.1%) 98(10.0%) 0.10 12(6.5%) 100(10.7%) 0.91
10th - 90th 88(80.7%) 801(81.6%) 151(82.1%) 760(81.2%)
>90th 10(9.2%) 83(8.5%) 21(11.4%) 76(8.1%)
Hip Circumference (cm) <10th 10(9.2%) 84(8.6%) 0.02 8(4.3%) 89(9.5%) 0.23
10th - 90th 84(77.1%) 811(82.6%) 152(82.6%) 767(81.9%)
>90th 15(13.8%) 87(8.9%) 24(13.0%) 80(8.5%)
Mid upper arm circumference (cm) <10th 11(10.1%) 104(10.6%) 0.0003 11(6%) 109(11.6%) 0.01
10th - 90th 78(71.6%) 790(80.4%) 142(77.2%) 749(80.0%)
>90th 20(18.3%) 88(9.0%) 31(16.8%) 78(8.3%)
Sum of skinfold thickness (mm) <10th 4(3.7%) 105(10.7%) 0.001 15(8.2%) 97(10.4%) <0.001
10th - 85th 77(70.6%) 744(75.8%) 125(67.9%) 720(76.9%)
>85th 28(25.7%) 133(13.5%) 44(23.9%) 119(12.7%)
Note: Bold indicates statistical signiﬁcance at 5%.
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Table 4 Logistic Regression Models: Effect of GDM and Obesity Adjusted for Potential Confounders on Neonatal Adiposity
Variables Sum of Skinfold Thickness
Univariate Model 1
Including
Obesity
Model 2
Including
GDM
Model 3 Obesity with
GDM and Interaction
Model 4
Obesity, GDM
Without Interaction
Unadjusted OR
(95% CI)
Adjusted OR (95% CI)
Participant’s obesity
status
Yes 2.21(1.38, 3.52) 2.18(1.35, 3.54) – 1.80(0.95, 3.40) 1.90(1.16, 3.12)
No 1 1 – 1 1
Current GDM status
during assessment
Yes 2.16(1.46, 3.18) – 2.18(1.45,
3.28)
1.93(1.21, 3.10) 1.99(1.31, 3.02)
No 1 – 1 1 1
Religion Hinduism 1.02(0.73, 1.43) 1.07(0.73, 1.58) 1.03(0.70, 1.51) 1.07(0.73, 1.58) 1.08(0.73, 1.58)
Christianity 1.35(0.57, 3.17) 1.45(0.60, 3.52) 1.50(0.62, 3.64) 1.52(0.63, 3.71) 1.52(0.63, 3.70)
Islam 1 1 1 1 1
MET values Low 1 1 1 1 1
Moderate 1.09(0.32, 3.73) 3.01(0.40, 22.87) 3.17(0.41,
24.32)
3.13(0.41, 24.09) 3.10(0.40, 23.88)
Participant’s history
of diabetes
Yes 1.78(0.48, 6.52) 1.65(0.41, 6.63) 2.07(0.52, 8.26) 1.81(0.44, 7.45) 1.81(0.44, 7.46)
No 1 1 1 1 1
Parity Nulliparous 1 1 1 1 1
Multiparous 1.17(0.83, 1.64) 1.19(0.81, 1.74) 1.22(0.83, 1.78) 1.19(0.81, 1.75) 1.19(0.81, 1.75)
Family history of
diabetes
None 1 1 1 1 1
One parent 1.10(0.73, 1.67) 1.09(0.70, 1.68) 1.04(0.67, 1.61) 1.03(0.66, 1.61) 1.03(0.66, 1.60)
Both parent 1.77(0.75, 4.20) 1.87(0.77, 4.58) 1.75(0.71, 4.30) 1.68(0.67, 4.18) 1.69(0.68, 4.20)
Husband’s alcohol
consumption status
Yes 1.33(0.85, 2.08) 1.41(0.87, 2.30) 1.40(0.86, 2.29) 1.43(0.87, 2.33) 1.42(0.87, 2.33)
No 1 1 1 1 1
Maternal age 1.00(0.96, 1.04) 0.99(0.94, 1.04) 0.98(0.94, 1.03) 0.98(0.93, 1.03) 0.98(0.93, 1.03)
Husband’s income 1.00(1.00, 1.00) 1.00(1.00, 1.00) 1.00(1.00, 1.00) 1.00(1.00, 1.00) 1.00(1.00, 1.00)
Participant’s height 1.01(0.98, 1.04) 1.02(0.99, 1.05) 1.02(0.99, 1.05) 1.02(0.99, 1.05) 1.02(0.99, 1.05)
Interaction (Obesity × GDM) p value=0.78 –
2log likelihood 868.65 865.88 859.77 857.77
Nagelkerke R Square 0.032 0.038 0.048 0.048
Hosmer & Lemeshow test χ2=4.82, p=0.77 χ2=4.89,
p=0.77
χ2=5.06, p=0.75 χ2=5.06, p=0.77
Classiﬁcation accuracy 85.2% 85.3% 85.3% 85.3%
Notes:Clinically relevant confounders have been included in themodel thought the p value is not less than 0.20. Model 1- Maternal obesity, maternal age, maternal height, Religion,
MET values, Husband’s income, Diabetes history in family, Parity, Husband’s alcohol consumption status. Model 2- GDM, maternal age, maternal height, Religion, MET values,
Husband’s income, Diabetes history in family, Parity, Husband’s alcohol consumption status. Model 3- Maternal obesity, GDM, interaction (Obesity × GDM), Age, Height, Religion,
MET values, Husband’s income, Diabetes history in family, Parity, Husband’s alcohol consumption status. Model 4 –Maternal obesity, GDM, maternal age, maternal height, Religion,
MET values, Husband’s income, Diabetes history in family, Parity, Husbands alcohol consumption status. Bold indicates statistical signiﬁcance at 5%.
Abbreviations: OR, Odds ratio; CI, conﬁdence interval.
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later in life in India. This concurs with earlier studies in
the ﬁeld, showing that maternal obesity is reﬂective of
overall lifestyle and genetics,67,68 whereas the effects of
GDM might be transient. Our results indicate that children
born to mothers who have obesity and GDM as a clustered
condition are programmed to a different growth trajectory
in early life. Recent evidence suggests that children of
obese mothers have increased BMI, blood pressure, and
carotid intima-media-adventitia thickness.69 Our results
indicate that there is a transgenerational effect of maternal
obesity and GDM in infants.
The strengths of our study are that it is by far the
largest pregnancy cohort in the public-sector health facil-
ities in India to assess the relationship between maternal
hyperglycemia and neonatal adiposity as a marker for later
chronic conditions. We established the cohort since
April 2016, and have included an almost equal proportion
of minority groups that mainly belong to the vulnerable
sections of the society. Our research staff was well trained,
the equipment is well-calibrated, and rigorous quality con-
trol measures are strictly followed, complying with the
standard operating procedures. Our ﬁndings inform policy
formulation for scaling up screening for GDM and man-
agement in all the public health facilities. The main limita-
tion is the unavailability of the pre-pregnancy BMI of the
enrolled participants. This reduced our ability to compare
gestational weight gain and its inﬂuence on neonatal adip-
osity. However, since our inclusion criteria include preg-
nant women that had completed more than 14 weeks of
gestational age, the weight before conception was out of
the scope of our study. No currently available method to
carry out sensitivity analysis was possible since the out-
come, exposure, and the mediator variable are
dichotomous.
Conclusion
Our study showed that maternal obesity and GDM are
independently related to neonatal adiposity in women
belonging to low and middle-income urban India. Also,
we found that GDM is a stronger determinant of neonatal
adiposity compared to maternal obesity. Since obesity
development is inﬂuenced in utero, screening, and man-
agement of obesity and GDM can limit the future epi-
demics of childhood obesity.
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OR (95% CI) p value
Natural direct effect 1.90(1.16, 3.10) 0.011*
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Marginal total effect 2.20(1.35, 3.58) 0.001*
Proportion mediated 0.252 –
Note: *Indicates statistical signiﬁcance at 5%.
Abbreviation: CI, conﬁdence interval.
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